Early efficacy of and toxicity from lutetium-177-DOTATATE treatment in patients with progressive metastatic NET

Abstract

Early outcomes of patients treated with Lu-DOTATATE are similar to those in previously published series in terms of end-of-treatment efficacy and toxicity. This provides further evidence that this is a safe and efficacious form of treatment for patients with progressive metastatic neuroendocrine tumours.